Oxford spinout OMass has pivoted from offering consulting services to developing its own drugs after closing a series A round backed by Oxford Sciences Innovation.

Hospitality shift work platform Qwick’s seed investors include UAVenture Capital Fund, an independent vehicle set up to cultivate University of Arizona’s ecosystem.

Ireland’s Comptroller and Auditor General has highlighted issues in a Waterford Institute of Technology licensing deal that garnered low returns when the spinout in question was acquired.

Rostock-founded 3D printer maker Aim3D has secured money from investors including Brose ahead of the launch of its first product in spring 2019.

Queensland spinout Pure Battery Technologies will use the cash to design and build production plants for its acid-leaching-based battery material manufacturing process.

Synthorx, spun out of Scripps Research Institute, is targeting $100m in a proposed offering half a year after it raised $63m in a series C round backed by Osage University Partners.

The biopharmaceutical spinout of University of Veterinary Medicine Vienna is issuing 400,000 shares in an initial public offering that is set to fetch between $34m and $41m.

Inflammatory disease drug developer Inflazome, based on research at University of Queensland and Trinity College Dublin, has added $45.6m in series B capital to its coffers.

John Lonsdale will oversee a new enterprise services team at Edinburgh Innovations tasked with matters including oversight of a local scheme targeting the formation of 400 data-orientated startups.

Vascugen has collected an undisclosed sum from investors including Indiana University Philanthropic Venture Fund to commercialise medicines for vascular-degenerative diseases based on IU technology.